Manchester Keith S's Form 4 filing
Roivant Sciences Ltd. (ROIV) · filed Jun 30, 2026
- Accession no.
- 0001193125-26-291172
- Filed
- Jun 30, 2026
- Trade date
- Jun 26-30, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $56.4M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Manchester Keith SCIK 0001244828 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Shares | SSaleDisposed | −300,783 | $33.92 | −$10,202,559.36 | 14,826,546 | Indirect | Duplicate filing |
| Jun 26, 2026 | Common Shares | SSaleDisposed | −325,000 | $34.07 | −$11,072,750 | 14,501,546 | Indirect | Duplicate filing |
| Jun 29, 2026 | Common Shares | SSaleDisposed | −200,000 | $34.44 | −$6,888,000 | 14,301,546 | Indirect | Duplicate filing |
| Jun 29, 2026 | Common Shares | SSaleDisposed | −600,000 | $34.59 | −$20,754,000 | 13,701,546 | Indirect | Duplicate filing |
| Jun 30, 2026 | Common Shares | SSaleDisposed | −12,380 | $35.28 | −$436,766.4 | 13,689,166 | Indirect | Duplicate filing |
| Jun 30, 2026 | Common Shares | SSaleDisposed | −200,000 | $35.45 | −$7,090,000 | 1,748,403 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.